## Mechanistic Overview
SPP1+ DAM as Source of Autoimmunity in Neurodegeneration starts from the claim that modulating SPP1, GALECTIN3, LGALS3, CXCR4 within the disease context of Alzheimer's disease can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview SPP1+ DAM as Source of Autoimmunity in Neurodegeneration starts from the claim that modulating SPP1, GALECTIN3, LGALS3, CXCR4 within the disease context of Alzheimer's disease can redirect a disease-rel
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.70
Evidence
0.66
Novelty
0.50
Feasibility
0.50
Impact
0.50
Druggability
0.00
Safety
0.00
Competition
0.00
Data
0.00
Reproducible
0.64
KG Connect
0.50
Score Breakdown
Dimension
SPP1+ DAM as Source of Autoimm
Mechanistic
0.700
Evidence
0.660
Novelty
0.500
Feasibility
0.500
Impact
0.500
Druggability
0.000
Safety
0.000
Competition
0.000
Data
0.000
Reproducible
0.640
KG Connect
0.500
Evidence
SPP1+ DAM as Source of Autoimmunity in Neurodegeneration